Jan. 28, 2013
/PRNewswire/ -- Leading events organiser,
, announced today that CPhI Southeast Asia, the first in its annual portfolio of global pharmaceutical ingredients events for 2013, will return this
to the Jakarta International Expo in
. With strong projections for attendance and rebookings already secured from high end exhibitors such as ACG, javaplant, BCN Peptides, Fuji Chemicals, Mensa Group, Procaps, Schott Pharma Packaging, Kalbe Group and SKY Softgel, this year's event will feature an increased offering of learning summits and training workshops along with two additional co-located industry events. New this year, CPhI Southeast Asia will include P-MEC for pharmaceutical machinery, laboratory equipment and analytical technology and InnoPack South East Asia for innovative packaging and drug delivery solutions.
The global CPhI portfolio centers on driving growth and innovation across the diverse sectors of the pharmaceutical industry. As part of this initiative, CPhI Southeast Asia debuted last year to highlight the vibrant ASEAN (Association of South East Asian Nations) market and offer attendees and exhibitors direct access to a region with strong government support for pharmaceutical production, a large population of prospective customers and a dynamic and growing economy. The event will be further complemented by the addition of the CPhI Southeast Asia Pharmaceutical Summit for 2013 which serves to deliver the latest in market insight with in-depth dialogues from global and local practitioners. The high-level summit programme will run in an add on format from
, offering exceptional networking opportunities and discussions on ASEAN harmonisation, trade and border regulations, the contract services industry in
and a local healthcare perspective with a full view into the pharmerging markets. Also of specific importance, the summit will cover IP protection, successfully bringing pharmaceuticals to market, generics production and alternative medicines.
In its first year, CPhI Southeast Asia made a big impression on exhibitors and attendees. "I am really impressed. Although it is the first time, it is really very good -- it is already an international standout CPhI event," commented
of Colorcon, an exhibiting company from
of DSM in
also noted that, "It has been a very encouraging experience particularly having had several of our key customers visit us."
CPhI Southeast Asia exists to expand exhibitor and visitor networks in the local ASEAN pharma market through a unique platform that facilitates face to face discussions that otherwise may not happen. The addition of P-MEC serves to highlight the growth of the finished dosage and generics sectors, which is currently being driven by rapid growth in the manufacture base of
. The introduction of InnoPack will further extend the scope of the event by bringing a focus to the important role that packaging plays in product development, safety, dosage and dispensing.
"The location in
is unique, as it offers a firsthand look into the ongoing harmonisation happening across the ASEAN region," noted UBM Live Pharma Event Manager
is currently the world's fourth most populous country with around 238 million people and a CAGR of 11 percent, which is well above the world's average. That said, this is a market that can bring significant benefits to our customer base, with CPhI Southeast Asia providing a unique opportunity to engage with industry leaders and decision makers from the region. We are pleased that the event was such a success in its first year with 220 exhibitors and 4,500 attendees, and we look forward to providing another focused, innovative event in a region that is actively building up infrastructure and encouraging foreign investment to our attendees and exhibitors in 2013."
The 2013 return of CPhI Southeast Asia, with the addition of P-MEC and InnoPack will offer an effective venue for pharma professionals to make valuable business connections and maximise ROI both in
and across the globe. Beyond the strong growth in
's pharma industry is expected to have a CAGR of 24 percent, with
and other countries in the region also poised for growth. The Deputy Minister of Health spoke to this huge growth potential at CPhI Southeast Asia last year, saying that, "Rapid population growth and the improving economy are factors that will increase drug consumption here. The government's 2014 social insurance programme has been designed to provide free healthcare for 76.4 million people, so if the poor people get sick, there is no need for them to pay, as everything is already paid for by the government. Under such a situation, we have many opportunities for investors and drug manufacturers to produce and meet the need and demand for drugs to the community."
To learn more about this growing market and CPhI Southeast Asia, please visit
The full schedule of annual UBM Live Pharma Portfolio of events includes: CPhI Russia (
10-11 April, 2013
at the Manege Central Exhibition Hall in St. Petersburg); CPhI, ICSE, P-MEC, BioPh and Pharmatec Japan (
24-26 April, 2013
at the Tokyo Big Sight Exhibition Centre in
); CPhI, P-MEC, ICSE, InnoPack, LABWorld, BioPh China (
25-27 June 2013
at the SNIEC in
); CPhI South America (
6-8 August, 2013
at the Expo Centre Norte,
Sao Paulo, Brazil
); CPhI Worldwide, ICSE, InnoPack, and P-MEC Europe (
22-24 October, 2013
at the Messe
); and CPhI, ICSE, P-MEC India and BioPh (
3-5 December, 2013
at the Bombay Exhibition Centre in
To learn more about these global events, please visit
About UBM Live
UBM Live is a division of UBM Plc (LSE: UBM) a leading provider of business information services to the maritime, travel, fashion, technology, healthcare, media, and property industries. UBM offers services in trade shows, online, news distribution, and publishing to customers across the globe. Its brands are represented in more than 30 countries and are organized into specialist teams that serve their business communities helping them excel in their market by working effectively and efficiently. For more information, go to
SOURCE UBM Live